Kaya Limited (KAYA.NS)
Mumbai, IN
Kaya Limited manages and operates a network of specialized clinics focused on dermatological and trichological well-being. The company delivers a wide spectrum of treatments addressing issues such as age-related skin concerns, pigmentation irregularities, acne and scar management, permanent laser hair reduction, hair loss prevention, surgical hair restoration, and solutions for dandruff or under-nourished hair. Additionally, it provides various aesthetic improvement services. Beyond its clinical offerings, Kaya also manufactures and distributes a diverse collection of hair and skin care products tailored for both men and women. These products are retailed through Kaya's own brand stores, numerous online platforms, third-party vendors, and its dedicated e-commerce site, shop.kaya.in. The company's operational footprint encompasses 71 clinics throughout India and an additional 23 establishments situated in the Middle East. Established in 2002, Kaya Limited is headquartered in Mumbai, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.27% | +2.10% | -5.47% | -24.15% | -37.08% | -37.25% | -24.91% | -25.88% | -14.19% | -72.95% | -82.46% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+2.4% Q1'26: +2.0% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-92.5% Q1'26: -114.3% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%-27.1% Q1'26: -29.6% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%-25.2% Q1'26: -22.5% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%-54.6% Q1'26: -48.9% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+10.3% Q1'26: +16.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×-24.61× Q1'26: -80.97× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.32B
est: 3.34B (-0.6%)
|
3.70B
est: 3.64B (+1.8%)
|
4.10B
est: 4.12B (-0.3%)
|
4.00B
est: 4.22B (-5.2%)
|
4.20B
est: 4.20B (+0.1%)
|
3.93B
est: 4.20B (-6.5%)
|
2.75B
est: 4.53B (-39.3%)
|
3.24B
est: 6.39B (-49.3%)
|
2.17B
est: 3.64B (-40.3%)
|
3.64B
3.64B – 3.64B
+0.0% YoY
|
4.12B
4.12B – 4.12B
+13.2% YoY
|
4.22B
4.22B – 4.22B
+2.4% YoY
|
4.20B
4.20B – 4.20B
-0.4% YoY
|
4.20B
4.20B – 4.20B
0.0% YoY
|
4.53B
4.53B – 4.53B
+7.8% YoY
|
| EBITDA |
472.33M
est: 163.16M (+189.5%)
|
257.99M
est: 177.41M (+45.4%)
|
-55.18M
est: 200.89M (-127.5%)
|
109.34M
est: 205.77M (-46.9%)
|
106.67M
est: 205.04M (-48.0%)
|
642.35M
est: 204.99M (+213.4%)
|
417.20M
est: 279.18M (+49.4%)
|
152.75M
est: 310.29M (-50.8%)
|
349.31M
est: 27.79M (+1,156.8%)
|
27.79M
27.79M – 27.79M
+0.0% YoY
|
31.47M
31.47M – 31.47M
+13.2% YoY
|
32.24M
32.24M – 32.24M
+2.4% YoY
|
32.12M
32.12M – 32.12M
-0.4% YoY
|
32.12M
32.12M – 32.12M
0.0% YoY
|
34.63M
34.63M – 34.63M
+7.8% YoY
|
| EBIT |
317.89M
est: -392.99M (+180.9%)
|
88.77M
est: -427.32M (+120.8%)
|
-305.09M
est: -483.87M (+36.9%)
|
-189.35M
est: -495.62M (+61.8%)
|
-184.16M
est: -493.86M (+62.7%)
|
-170.81M
est: -493.74M (+65.4%)
|
-184.25M
est: -249.20M (+26.1%)
|
-383.25M
est: -755.14M (+49.2%)
|
-27.10M
est: -561.67M (+95.2%)
|
-561.67M
-561.67M – -561.67M
+0.0% YoY
|
-635.99M
-635.99M – -635.99M
-13.2% YoY
|
-651.44M
-651.44M – -651.44M
-2.4% YoY
|
-649.12M
-649.12M – -649.12M
+0.4% YoY
|
-648.97M
-648.97M – -648.97M
+0.0% YoY
|
-699.80M
-699.80M – -699.80M
-7.8% YoY
|
| Net Income |
317.83M
est: 378.08M (-15.9%)
|
87.98M
est: 133.44M (-34.1%)
|
-8.21M
est: 2.62M (-413.7%)
|
-211.34M
est: -88.96M (-137.6%)
|
-159.64M
est: -23.55M (-577.9%)
|
-544.24M
est: -133.44M (-307.9%)
|
-380.14M
est: -603.90M (+37.1%)
|
-688.37M
est: 317.76B (-100.2%)
|
-453.22M
est: 147.14M (-408.0%)
|
147.14M
147.14M – 147.14M
+0.0% YoY
|
2.89M
2.89M – 2.89M
-98.0% YoY
|
-98.09M
-98.09M – -98.09M
-3,500.0% YoY
|
-25.97M
-25.97M – -25.97M
+73.5% YoY
|
-147.14M
-147.14M – -147.14M
-466.7% YoY
|
-87.99M
-87.99M – -87.99M
+40.2% YoY
|
| SGA |
637.16M
est: 494.37M (+28.9%)
|
703.29M
est: 537.55M (+30.8%)
|
1.22B
est: 3.11B (-60.7%)
|
660.89M
est: 623.47M (+6.0%)
|
603.58M
est: 621.25M (-2.8%)
|
599.46M
est: 621.11M (-3.5%)
|
397.41M
est: 2.89B (-86.2%)
|
514.40M
est: 3.21B (-84.0%)
|
184.25M
est: 812.31M (-77.3%)
|
812.31M
812.31M – 812.31M
+0.0% YoY
|
919.79M
919.79M – 919.79M
+13.2% YoY
|
942.14M
942.14M – 942.14M
+2.4% YoY
|
938.79M
938.79M – 938.79M
-0.4% YoY
|
938.57M
938.57M – 938.57M
0.0% YoY
|
1.01B
1.01B – 1.01B
+7.8% YoY
|
| EPS |
24.64
est: 28.90 (-14.7%)
|
6.82
est: 10.20 (-33.1%)
|
-0.63
est: 0.20 (-415.0%)
|
-16.22
est: -6.80 (-138.5%)
|
-12.23
est: -1.80 (-579.4%)
|
-41.66
est: -10.20 (-308.4%)
|
-29.10
est: -6.10 (-377.0%)
|
-52.69
est: 24,168.71 (-100.2%)
|
-34.64
est: 10.20 (-439.6%)
|
10.20
10.20 – 10.20
+0.0% YoY
|
0.20
0.20 – 0.20
-98.0% YoY
|
-6.80
-6.80 – -6.80
-3,500.0% YoY
|
-1.80
-1.80 – -1.80
+73.5% YoY
|
-10.20
-10.20 – -10.20
-466.7% YoY
|
-6.10
-6.10 – -6.10
+40.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-25 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Arihant Dhariwal | Chief Financial Officer | 8M | male |
| Nitika Sunny Dalmia | Company Secretary & Compliance Officer | 3M | female |
| Dhivya Ashok | Chief Operating Officer for South & East Regions | — | female |
| Harshraj Charandas Mariwala | Chairman & MD | — | — |
| Lokesh Wagadre | Vice President and Head of Information & Technology | — | male |
| Nishant Nayyar | Vice President & Head of Marketing | — | male |
| Piyush Jaiswal | Chief Operating Officer of North & West | — | male |
| Amrita Chowdhury | Vice President & Head of Human Resources | — | female |
| Saurav Jha | Chief Business Transformation Officer | — | male |
| Aparna Santhanam | Head Medical Operations | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KAYA.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
